Our findings of upregulated VEGFA levels in ADPKD and CKD are in support of these results and might be of special interest, as there are VEGF-, VEGF receptor- but also HIF-1α-antagonists discussed as therapeutic options [42,43]. The gene discussed is VEGFA; the disease is chronic kidney disease.